Touchlight extends funding round to US$125M as demand for its dbDNA™ grows rapidly
Touchlight and Vanderbilt University Medical Center collaborate on DARPA Pandemic Prevention Platform programme to develop synthetic DNA-based antibody to protect against emerging threats
Touchlight raises £42 million ($58 million) to meet unprecedented global DNA demand
Touchlight appoints Satish Muchakayala as Director of Regulatory Affairs
John Dwyer joins Touchlights board of directors
Touchlight wins prestigious Lloyds Bank National Business Award
Touchlight appoints Karen Fallen as CEO of Touchlight DNA Services
Touchlight Genetics and Stonehaven Incubate form Touchlight Aquaculture
Touchlight announces development of a vaccine against COVID-19
Cancer Research UK, University of Southampton and Touchlight Genetics Partner to develop head and neck cancer vaccine
Touchlight to develop biobatteries with potential to address limitations of portable power supply
Touchlights’s chairman to help lead UK COVID-19 vaccine effort
World Vaccine Congress
Join us at World Vaccine Congress, Washington DC (Apr 3-6, 2023).
Dr Lisa Caproni, Head of Vaccine Discovery, will be presenting on the topic “A rapid response platform for nucleic acid vaccines”.
Meet up with us and learn how our doggybone DNA can be used to enable faster, safer and more scalable DNA production than other traditional methods without contamination of the plasmid DNA backbone.